These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

162 related items for PubMed ID: 23033124

  • 1. A new paradigm in viral resistance.
    Ruiz A, Russell SJ.
    Cell Res; 2012 Nov; 22(11):1515-7. PubMed ID: 23033124
    [Abstract] [Full Text] [Related]

  • 2. Combating enterovirus replication: state-of-the-art on antiviral research.
    Thibaut HJ, De Palma AM, Neyts J.
    Biochem Pharmacol; 2012 Jan 15; 83(2):185-92. PubMed ID: 21889497
    [Abstract] [Full Text] [Related]

  • 3. Antiviral Combination Approach as a Perspective to Combat Enterovirus Infections.
    Galabov AS, Nikolova I, Vassileva-Pencheva R, Stoyanova A.
    Pril (Makedon Akad Nauk Umet Odd Med Nauki); 2015 Jan 15; 36(2):91-9. PubMed ID: 27442375
    [Abstract] [Full Text] [Related]

  • 4. Inhibition of enterovirus 71 by adenosine analog NITD008.
    Deng CL, Yeo H, Ye HQ, Liu SQ, Shang BD, Gong P, Alonso S, Shi PY, Zhang B.
    J Virol; 2014 Oct 15; 88(20):11915-23. PubMed ID: 25100827
    [Abstract] [Full Text] [Related]

  • 5. Antiviral screen identifies EV71 inhibitors and reveals camptothecin-target, DNA topoisomerase 1 as a novel EV71 host factor.
    Wu KX, Chu JJ.
    Antiviral Res; 2017 Jul 15; 143():122-133. PubMed ID: 28427827
    [Abstract] [Full Text] [Related]

  • 6. Direct-acting antivirals and host-targeting strategies to combat enterovirus infections.
    Bauer L, Lyoo H, van der Schaar HM, Strating JR, van Kuppeveld FJ.
    Curr Opin Virol; 2017 Jun 15; 24():1-8. PubMed ID: 28411509
    [Abstract] [Full Text] [Related]

  • 7. Antivirals against enteroviruses: a critical review from a public-health perspective.
    Benschop KS, van der Avoort HG, Duizer E, Koopmans MP.
    Antivir Ther; 2015 Jun 15; 20(2):121-30. PubMed ID: 25643052
    [Abstract] [Full Text] [Related]

  • 8. Drug discovery in enteroviral infections.
    Chen TC, Shih SR.
    Infect Disord Drug Targets; 2011 Jun 15; 11(3):337-45. PubMed ID: 21488833
    [Abstract] [Full Text] [Related]

  • 9. The capsid binder Vapendavir and the novel protease inhibitor SG85 inhibit enterovirus 71 replication.
    Tijsma A, Franco D, Tucker S, Hilgenfeld R, Froeyen M, Leyssen P, Neyts J.
    Antimicrob Agents Chemother; 2014 Nov 15; 58(11):6990-2. PubMed ID: 25199773
    [Abstract] [Full Text] [Related]

  • 10. Mutations in the nonstructural protein 3A confer resistance to the novel enterovirus replication inhibitor TTP-8307.
    De Palma AM, Thibaut HJ, van der Linden L, Lanke K, Heggermont W, Ireland S, Andrews R, Arimilli M, Al-Tel TH, De Clercq E, van Kuppeveld F, Neyts J.
    Antimicrob Agents Chemother; 2009 May 15; 53(5):1850-7. PubMed ID: 19237651
    [Abstract] [Full Text] [Related]

  • 11. Prunin suppresses viral IRES activity and is a potential candidate for treating enterovirus A71 infection.
    Gunaseelan S, Wong KZ, Min N, Sun J, Ismail NKBM, Tan YJ, Lee RCH, Chu JJH.
    Sci Transl Med; 2019 Oct 30; 11(516):. PubMed ID: 31666401
    [Abstract] [Full Text] [Related]

  • 12. Therapeutic targets for enterovirus infections.
    Laajala M, Reshamwala D, Marjomäki V.
    Expert Opin Ther Targets; 2020 Aug 30; 24(8):745-757. PubMed ID: 32552314
    [Abstract] [Full Text] [Related]

  • 13. Special Issue "Enteroviruses 2021".
    Ho HY.
    Viruses; 2022 Feb 02; 14(2):. PubMed ID: 35215899
    [Abstract] [Full Text] [Related]

  • 14. Antidepressant Sertraline Is a Broad-Spectrum Inhibitor of Enteroviruses Targeting Viral Entry through Neutralization of Endolysosomal Acidification.
    Tseng KC, Hsu BY, Ling P, Lu WW, Lin CW, Kung SH.
    Viruses; 2022 Jan 08; 14(1):. PubMed ID: 35062313
    [Abstract] [Full Text] [Related]

  • 15. Viral engagement with host receptors blocked by a novel class of tryptophan dendrimers that targets the 5-fold-axis of the enterovirus-A71 capsid.
    Sun L, Lee H, Thibaut HJ, Lanko K, Rivero-Buceta E, Bator C, Martinez-Gualda B, Dallmeier K, Delang L, Leyssen P, Gago F, San-Félix A, Hafenstein S, Mirabelli C, Neyts J.
    PLoS Pathog; 2019 May 08; 15(5):e1007760. PubMed ID: 31071193
    [Abstract] [Full Text] [Related]

  • 16. The life cycle of non-polio enteroviruses and how to target it.
    Baggen J, Thibaut HJ, Strating JRPM, van Kuppeveld FJM.
    Nat Rev Microbiol; 2018 Jun 08; 16(6):368-381. PubMed ID: 29626210
    [Abstract] [Full Text] [Related]

  • 17. Antivirals blocking entry of enteroviruses and therapeutic potential.
    Anasir MI, Zarif F, Poh CL.
    J Biomed Sci; 2021 Jan 15; 28(1):10. PubMed ID: 33451326
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Strategies to develop antivirals against enterovirus 71.
    Kuo RL, Shih SR.
    Virol J; 2013 Jan 22; 10():28. PubMed ID: 23339605
    [Abstract] [Full Text] [Related]

  • 20. [Exploration for anti-enterovirus compounds and analysis on the mechanism of its inhibitory effect on virus infection].
    Arita M.
    Uirusu; 2013 Jan 22; 63(1):93-102. PubMed ID: 24769585
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.